The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
UMC Utrecht
ViroMissile, Inc.
AstraZeneca
Duke University
Washington University School of Medicine
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Eli Lilly and Company
IDEAYA Biosciences
Institut du Cancer de Montpellier - Val d'Aurelle
Hospices Civils de Lyon
Alliance for Clinical Trials in Oncology
Daiichi Sankyo
Memorial Sloan Kettering Cancer Center
University of Nebraska
Eli Lilly and Company
Oscotec Inc.
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
University of Michigan
Innate Pharma